Skip to content
BoldPortal

The Zimbabwean Government Rejects ‘Unbalanced’ US Healthcare Assistance Agreement Over Information Fears

Health funding image
The proposed American financial assistance was intended for initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

Zimbabwe has declined a significant US healthcare agreement valued at 367 million US dollars (£272m) over five years because of Washington's request for sensitive information.

The decision was revealed following a official document from December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".

A government spokesperson later explained that the United States was seeking health data for research and profit but refused to share the benefits from any future treatments.

"We are forced to start the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has called for continued dialogue to reach a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.

Wider Implications

This development comes after a comparable situation in Kenya, where a high court halted a similar health funding agreement after concerns were filed about the safety of citizens' health data.

Since returning to office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

USAID had overseen aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing government-to-government agreements to boost openness and accountability.

Based on statements, Sixteen nations in Africa have so far agreed to these new agreements, representing more than $18.3bn of fresh investment.

Specifics of the Rejected Deal

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this collaboration could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment via US-supported programmes," Tremont said.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that provided information," Mangwana explained.

"In essence, our country would provide the basic resources for scientific discovery without any assurance that the end products would be accessible to our people if a new health crisis arise."

National Interest and Global Health

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting structures already established via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage potential global health emergencies.

"This mechanism is designed to ensure that when a nation provides its samples, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to create them."

The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.

"We encourage further dialogue with our American counterparts on how future collaboration could be arranged in a manner that honours the independence and dignity of both nations."

Health Experts Response

Medical experts expressed it understood the government's concerns, but recommended that negotiations should continue considering much of the country's HIV programmes were funded by international support.

"In cases where technical issues exist, including those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it added.

The situation underscores the continuing challenges between receiving vital international aid and protecting a country's data in an increasingly data-driven world.

By

Anthony Ward

A tech journalist and digital strategist with over a decade of experience covering AI, cybersecurity, and emerging technologies across Europe.

BoldPortal

Type to search articles.